BidaskClub upgraded shares of Sientra (NASDAQ:SIEN) from a sell rating to a hold rating in a research report report published on Friday morning.
A number of other analysts have also recently commented on SIEN. Canaccord Genuity initiated coverage on shares of Sientra in a research note on Monday, August 28th. They set a buy rating and a $14.00 price target on the stock. William Blair upgraded shares of Sientra from a market perform rating to an outperform rating in a research note on Wednesday, September 13th. Finally, Stifel Nicolaus restated a hold rating and set a $14.00 price target (up from $11.00) on shares of Sientra in a research note on Wednesday, September 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of $13.75.
Sientra (SIEN) opened at $15.26 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.87 and a quick ratio of 1.92. Sientra has a 52 week low of $7.20 and a 52 week high of $16.68.
A number of institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its holdings in Sientra by 23.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 18,660 shares of the medical instruments supplier’s stock worth $181,000 after acquiring an additional 3,534 shares during the period. Parametric Portfolio Associates LLC increased its holdings in Sientra by 23.0% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 20,180 shares of the medical instruments supplier’s stock worth $196,000 after acquiring an additional 3,770 shares during the period. Schroder Investment Management Group increased its holdings in Sientra by 1.1% during the 3rd quarter. Schroder Investment Management Group now owns 437,276 shares of the medical instruments supplier’s stock worth $6,730,000 after acquiring an additional 4,815 shares during the period. Nationwide Fund Advisors increased its holdings in Sientra by 260.4% during the 2nd quarter. Nationwide Fund Advisors now owns 10,963 shares of the medical instruments supplier’s stock worth $107,000 after acquiring an additional 7,921 shares during the period. Finally, JPMorgan Chase & Co. bought a new stake in Sientra during the 2nd quarter worth approximately $101,000. 76.63% of the stock is currently owned by institutional investors and hedge funds.
WARNING: This piece of content was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://sportsperspectives.com/2017/12/18/sientra-sien-lifted-to-hold-at-bidaskclub.html.
Sientra Company Profile
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.